Autotransfusion in prostatic hypertrophy surgery

Abstract

The variation of perioperative and postoperative hemochromocytometric parameters in patients who have undergone suprapubic prostatectomy and TURP due to prostatic hypertrophy, according to the type of transfusion (autotransfused and non-autotransfused patients: patients with both autologous and homologous transfusion; patients with homologous transfusion only), have been examined by the authors in their survey. Autotransfusion maintained hemochromocytometric parameters within safety limits without any homologous transfusion thus confirming literature data. In all the groups, a remarkable decrease in hematocrit, hemoglobin and red cells has been reported. No remarkable differences between autotransfused patients and patients without transfusion have been reported. Differences are significant in the group of patients with homologous transfusion. In autotransfused patients decrease in platelets is notable. In this way, hematic viscosity and relevant decrease of the thrombo-embolic risk is demonstrated.